- In November 2024, Boehringer Ingelheim’s vaccine for Leptospirosis in dogs is designed to protect against the bacteria Leptospira that cause the disease. This vaccine provides immunity against the most common strains of Leptospira, which can lead to severe liver and kidney damage, and can even be fatal. By vaccinating dogs, pet owners can significantly reduce the risk of infection from environmental exposure to contaminated water or soil. The vaccine promotes long-lasting protection, contributing to overall dog health and preventing the spread of the disease to other animals or humans, ensuring safer environments for pets and their families
- In November 2024, Boehringer Ingelheim launches Vetmedin Oral Solution for dogs with congestive heart failure (CHF). This new formulation offers an easy-to-administer solution to improve heart function in dogs suffering from CHF, a condition often caused by mitral valve disease or dilated cardiomyopathy. Vetmedin works by enhancing the heart’s ability to pump blood and reducing symptoms like coughing, fatigue, and difficulty breathing. This solution provides a convenient treatment option, helping to improve the quality of life and longevity of affected dogs, making heart failure management more effective and accessible for pet owners and veterinarians alike
- In September, Merck Animal Health has received EU marketing authorization for PORCILIS PCV M Hyo ID, an intradermal, needle-free swine vaccine protecting against PCV2 and M. hyo. Delivered via IDAL technology, it offers efficient, low-volume administration with enhanced animal welfare. Launching in Q1 2025, the vaccine supports sustainability, co-administration with other vaccines, and improved disease protection for piglets
- In July 2020, Zoetis has acquired Fish Vet Group from Benchmark Holdings to enhance its Pharmaq aquaculture business. The acquisition expands Pharmaq’s diagnostic and environmental testing capabilities across key markets, including the UK, Norway, Ireland, and Chile. Fish Vet Group’s services support sustainable aquaculture by aiding disease management, environmental compliance, and site assessments, strengthening Zoetis’ position in global fish health solutions
